A fond farewell: Marc lab becomes Jones lab with the retirement of Robert E. Marc, PhD.

Learn More

Solving the puzzle of glaucoma: Researcher David Krizaj discovers key similarities between cell injury in glaucoma and blast trauma injuries sustained by soldiers.

Learn More

Steele Center for Translational Medicine: World’s largest research eye bank yields new insights into age-related macular degeneration

Learn More


As a key part of the John A. Moran Eye Center’s vision that “no person with a blinding condition should be without hope, understanding, and treatment,” we invest heavily in both basic and translational research. Moran has 16 labs and more than 60 PhD researchers addressing a number of conditions including glaucoma, age-related macular degeneration, Stargardt, optic neuritis, retinal stroke, idiopathic intracranial hypertension, Usher syndrome, and retinopathy of prematurity. In 2016, the Moran Eye Center ranked seventh for National Institutes of Health funding.

Key Research Initiatives

Our key research initiatives at the Moran Eye Center include the following:

Intermountain Ocular Research Center

goldfish-retinaMoran is home to the Intermountain Ocular Research Center a nonprofit, independent laboratory that performs basic, in-depth scientific research on intraocular lenses. In addition, the Center provides services and education to surgeons, clinical ophthalmologists, their patients, and intraocular lens manufacturers worldwide.

Retinal Connectome for Vision

visionThe Marc Lab at the Moran Eye Center, working with teams at the University of Utah Scientific Computing and Imaging Institute and the University of Colorado Boulder, completed the first connectome dataset: the Retinal Connectome for Vision. The tools used to build this connectome are revolutionizing neuroanatomy and have been made freely available to all scientists world-wide.

Sharon Eccles Steele Center for Translational Medicine (SCTM)

microscopeThe Sharon Eccles Steele Center for Translational Medicine was established in 2009 to more quickly and cost-effectively turn scientific discoveries into clinically effective diagnostics and therapies for blinding eye conditions, and is currently focused on finding a better treatment for age-related macular degeneration. The SCTM is directed by Gregory S. Hageman, PhD.